ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells

Lignende værker

• Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy
  af: Gibbons, Don L., et al.
  Udgivet: (2014)
• Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase
  af: Wu, Ji, et al.
  Udgivet: (2008)
• Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
  af: Wu, Ji, et al.
  Udgivet: (2008)
• Molecular biology of bcr-abl1–positive chronic myeloid leukemia
  af: Quintás-Cardama, Alfonso, et al.
  Udgivet: (2009)
• Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance
  af: Chandra, Joya, et al.
  Udgivet: (2006)